RA
MCID: RHM011
MIFTS: 89

Rheumatoid Arthritis (RA) malady

Categories: Genetic diseases, Bone diseases, Rare diseases, Respiratory diseases

Aliases & Classifications for Rheumatoid Arthritis

Aliases & Descriptions for Rheumatoid Arthritis:

Name: Rheumatoid Arthritis 54 38 12 25 66 52 41 3 14 69
Arthritis, Rheumatoid 25 29 42
Ra 25 66 3
Rheumatoid Arthritis, Progression of 54 13
Arthritis or Polyarthritis, Rheumatic 12
Atrophic Arthritis 12

Classifications:



External Ids:

OMIM 54 180300
Disease Ontology 12 DOID:7148
ICD9CM 35 714.0
MeSH 42 D001172
NCIt 47 C27206 C2884
MedGen 40 C0003873
UMLS 69 C0003873

Summaries for Rheumatoid Arthritis

MedlinePlus : 41 rheumatoid arthritis (ra) is a form of arthritis that causes pain, swelling, stiffness and loss of function in your joints. it can affect any joint but is common in the wrist and fingers. more women than men get rheumatoid arthritis. it often starts in middle age and is most common in older people. you might have the disease for only a short time, or symptoms might come and go. the severe form can last a lifetime. rheumatoid arthritis is different from osteoarthritis, the common arthritis that often comes with older age. ra can affect body parts besides joints, such as your eyes, mouth and lungs. ra is an autoimmune disease, which means the arthritis results from your immune system attacking your body's own tissues. no one knows what causes rheumatoid arthritis. genes, environment, and hormones might contribute. treatments include medicine, lifestyle changes, and surgery. these can slow or stop joint damage and reduce pain and swelling. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary : Rheumatoid Arthritis, also known as arthritis, rheumatoid, is related to tuberculosis and hepatitis, and has symptoms including abnormality of the immune system, abnormality of the nervous system and vasculitis. An important gene associated with Rheumatoid Arthritis is PTPN22 (Protein Tyrosine Phosphatase, Non-Receptor Type 22), and among its related pathways/superpathways are Rheumatoid arthritis and Innate Immune System. The drugs Methotrexate and Abatacept have been mentioned in the context of this disorder. Affiliated tissues include Cartilage, t cells and bone, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 An arthritis that is an autoimmune disease which attacks healthy cells and tissue located in joint.

Genetics Home Reference : 25 Rheumatoid arthritis is a disease that causes chronic abnormal inflammation, primarily affecting the joints. The most common signs and symptoms are pain, swelling, and stiffness of the joints. Small joints in the hands and feet are involved most often, although larger joints (such as the shoulders, hips, and knees) may become involved later in the disease. Joints are typically affected in a symmetrical pattern; for example, if joints in the hand are affected, both hands tend to be involved. People with rheumatoid arthritis often report that their joint pain and stiffness is worse when getting out of bed in the morning or after a long rest.

OMIM : 54 Rheumatoid arthritis is an inflammatory disease, primarily of the joints, with autoimmune features and a complex... (180300) more...

CDC : 3 Redirect to https://www.cdc.gov/arthritis/basics/rheumatoid-arthritis.html

UniProtKB/Swiss-Prot : 66 Rheumatoid arthritis: An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures.

Wikipedia : 71 Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. It typically... more...

Related Diseases for Rheumatoid Arthritis

Diseases in the Rheumatoid Arthritis family:

Rheumatoid Arthritis, Systemic Juvenile

Diseases related to Rheumatoid Arthritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 880)
id Related Disease Score Top Affiliating Genes
1 tuberculosis 31.3 CCL2 IL10 IL17A IL1B IL6 TNF
2 hepatitis 31.2 HLA-DRB1 IFNG IL10 IL6 TNF
3 neuropathy 30.8 IL1B IL6 TNF
4 cryptococcosis 30.7 HLA-DRB1 IL10 IL17A TNF TNFRSF1B
5 osteonecrosis 30.7 IL1B IL6 MMP1 MMP3 TNF TNFSF11
6 pyoderma gangrenosum 30.7 IFNG IL1B IL6 TNF
7 myocardial infarction 30.7 CCL2 CIITA IL10 IL1B IL6 MMP3
8 histiocytosis 30.6 IL17A IL1A IL1B IL1RN IL6 MMP1
9 subcorneal pustular dermatosis 30.6 CCL2 IFNG IL10 IL17A IL1B IL6
10 collagenous colitis 30.6 IFNG IL10 IL17A IL1B IL6 TNF
11 celiac disease 30.6 IL17A IL1RN MMP3 TNF TNFRSF1B TNFSF11
12 pulmonary tuberculosis 30.5 IFNG IL10 IL6 TNF
13 nonspecific interstitial pneumonia 30.4 IFNG IL10 IL6 TNF
14 central nervous system lymphoma 30.3 CCL2 IL10 IL1B IL6 TNF
15 chorioretinitis 30.3 HLA-DRB1 IFNG IL10 PTPN22 TNF TNFRSF1B
16 dermatitis herpetiformis 30.3 IL17A MMP3 TNF TNFRSF1B
17 pyelonephritis 30.1 IL10 IL1B TNF
18 keratoconus 30.1 IL17A IL1B IL1RN IL6 MMP3 TNF
19 choroiditis 30.1 CCL2 IL10 IL1B IL6 TNF
20 swine influenza 30.1 HLA-DRB1 IL1A IL6 TNF
21 measles 30.1 IL1B IL6 TNF
22 immune-complex glomerulonephritis 30.0 CCL2 IFNG IL6
23 impotence 30.0 IFNG IL1A TNFSF11
24 urticaria 29.9 IL1B SLC22A4 TNF
25 rheumatoid arthritis, systemic juvenile 12.6
26 ras-associated autoimmune leukoproliferative disorder 12.3
27 felty syndrome 12.1
28 arthritis 11.8
29 rheumatoid lung disease 11.6
30 adult-onset still's disease 11.5
31 rheumatoid vasculitis 11.5
32 sjogren's syndrome 11.3
33 systemic onset juvenile idiopathic arthritis 11.3
34 psoriasis 11.2
35 palindromic rheumatism 11.2
36 scleritis 11.2
37 mixed connective tissue disease 11.2
38 bronchiolitis obliterans 11.2
39 progressive multifocal leukoencephalopathy 11.2
40 rheumatoid nodulosis 11.2
41 caplan's syndrome 11.2
42 necrobiosis lipoidica 11.2
43 cryptogenic organizing pneumonia 11.2
44 collagen disease 11.2
45 systemic scleroderma 11.2
46 temporomandibular ankylosis 11.2
47 polyarticular onset juvenile idiopathic arthritis 11.1
48 carpal tunnel syndrome, familial 11.1
49 arthropathy, progressive pseudorheumatoid, of childhood 11.0
50 multicentric carpotarsal osteolysis syndrome 11.0

Comorbidity relations with Rheumatoid Arthritis via Phenotypic Disease Network (PDN): (show all 33)


Active Peptic Ulcer Disease Acute Cystitis
Adrenal Cortical Hypofunction Bronchiectasis
Bronchitis Chronic Rheumatic Pericarditis
Decubitus Ulcer Deficiency Anemia
Esophagitis Felty Syndrome
Heart Disease Hypersensitivity Vasculitis
Hypertension, Essential Hypothyroidism
Idiopathic Interstitial Pneumonia Iron Deficiency Anemia
Mononeuropathy of the Median Nerve, Mild Neutropenia
Olecranon Bursitis Oral Candidiasis
Osteoarthritis Osteoporosis
Perforated Corneal Ulcer Pituitary Adenoma, Acth-Secreting
Postinflammatory Pulmonary Fibrosis Primary Immunodeficiency Disease
Protein-Energy Malnutrition Rheumatoid Lung Disease
Scleritis Sjogren's Syndrome
Spondyloarthropathy 1 Systemic Lupus Erythematosus
Temporal Arteritis

Graphical network of the top 20 diseases related to Rheumatoid Arthritis:



Diseases related to Rheumatoid Arthritis

Symptoms & Phenotypes for Rheumatoid Arthritis

Symptoms by clinical synopsis from OMIM:

180300

Clinical features from OMIM:

180300

Human phenotypes related to Rheumatoid Arthritis:

32 (show all 6)
id Description HPO Frequency HPO Source Accession
1 abnormality of the immune system 32 HP:0002715
2 abnormality of the nervous system 32 HP:0000707
3 vasculitis 32 HP:0002633
4 abnormality of blood and blood-forming tissues 32 HP:0001871
5 abnormality of the respiratory system 32 HP:0002086
6 rheumatoid arthritis 32 HP:0001370

UMLS symptoms related to Rheumatoid Arthritis:


back pain, muscle cramp, sciatica

MGI Mouse Phenotypes related to Rheumatoid Arthritis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.28 CD244 CIITA IFNG IL10 IL17A IL1A
2 immune system MP:0005387 10.28 MMP3 PADI4 PTPN22 SLC22A4 TNF TNFRSF1B
3 homeostasis/metabolism MP:0005376 10.27 IL6 MMP1 MMP3 NFKBIL1 PTPN22 SLC22A4
4 endocrine/exocrine gland MP:0005379 10.09 IFNG IL10 IL17A IL6 PTPN22 TNF
5 digestive/alimentary MP:0005381 10.06 IFNG IL10 IL17A IL6 PTPN22 SLC22A4
6 integument MP:0010771 9.91 IFNG IL10 IL1A IL1B IL1RN IL6
7 neoplasm MP:0002006 9.81 TNFRSF1B TNFSF11 IFNG IL10 IL1A IL1B
8 respiratory system MP:0005388 9.56 IFNG IL10 IL17A IL6 PTPN22 TNF
9 skeleton MP:0005390 9.4 CIITA IFNG IL10 IL17A IL1B IL1RN

Drugs & Therapeutics for Rheumatoid Arthritis

Drugs for Rheumatoid Arthritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 579)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methotrexate Approved Phase 4,Phase 2,Phase 3,Phase 1 1959-05-2, 59-05-2 126941
2
Abatacept Approved Phase 4,Phase 3,Phase 2,Phase 1 332348-12-6 10237
3
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
4
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 185243-69-0
5
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
6
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1 174722-31-7 10201696
7
Hydroxychloroquine Approved Phase 4,Phase 3,Phase 2,Phase 1 118-42-3 3652
8
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
9
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 2 16590-41-3 5360515
10
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
11
Sulfasalazine Approved Phase 4,Phase 3,Phase 2 599-79-1 5353980 5359476
12
Leflunomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75706-12-6 3899
13
Diclofenac Approved, Vet_approved Phase 4,Phase 3,Phase 2 15307-86-5 3033
14
Etoricoxib Approved, Investigational Phase 4,Phase 3,Phase 2 202409-33-4 123619
15
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1 428863-50-7
16
Dimethyl fumarate Approved, Investigational Phase 4,Phase 2 624-49-7 637568 5271565
17
Zinc Approved Phase 4 7440-66-6 32051 23994
18
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 169590-42-5 2662
19
Naproxen Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22204-53-1 1302 156391
20
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Phase 1 103-90-2 1983
21
Everolimus Approved Phase 4,Phase 1,Phase 2 159351-69-6 6442177
22
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 22916-47-8 4189
23
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 128794-94-5 5281078
24
Mycophenolic acid Approved Phase 4,Phase 3,Phase 1,Phase 2 24280-93-1 446541
25
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
26
Sirolimus Approved, Investigational Phase 4,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
27
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
28
Calcium carbonate Approved Phase 4,Phase 3,Phase 2 471-34-1
29
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
30
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 79217-60-0, 59865-13-3 5284373 6435893
31
Aspirin Approved, Vet_approved Phase 4,Phase 2 50-78-2 2244
32
chloroquine Approved, Vet_approved Phase 4,Phase 3,Phase 2 54-05-7 2719
33
Ethanol Approved Phase 4,Phase 2 64-17-5 702
34
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 50-02-2 5743
35
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
36
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
37
Benzocaine Approved Phase 4,Phase 3,Phase 2 1994-09-7, 94-09-7 2337
38
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 124-94-7 31307
39
Norepinephrine Approved Phase 4 51-41-2 439260
40
Milnacipran Approved Phase 4 92623-85-3 65833
41
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
42
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
43
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754 657311
44
Teriparatide Approved, Investigational Phase 4 52232-67-4 16133850
45
Minocycline Approved, Investigational Phase 4,Phase 3 10118-90-8 5281021
46
Betamethasone Approved, Vet_approved Phase 4,Phase 1,Phase 2 378-44-9 9782
47
Diphenhydramine Approved Phase 4 58-73-1, 147-24-0 3100
48
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75614-87-8, 51-45-6 774
49
Promethazine Approved Phase 4 60-87-7 4927
50
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345

Interventional clinical trials:

(show top 50) (show all 2406)
id Name Status NCT ID Phase
1 Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis Unknown status NCT02087696 Phase 4
2 Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis Unknown status NCT01000441 Phase 4
3 Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI Unknown status NCT01893151 Phase 4
4 Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis Unknown status NCT01301703 Phase 4
5 TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis Unknown status NCT00908089 Phase 4
6 Remission Induction in Very Early Rheumatoid Arthritis Unknown status NCT00523692 Phase 4
7 Targeting Synovitis in Early Rheumatoid Arthritis Unknown status NCT00920478 Phase 4
8 Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid Arthritis Unknown status NCT02275299 Phase 4
9 Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis Unknown status NCT01002716 Phase 4
10 Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker Unknown status NCT01072058 Phase 4
11 Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes Unknown status NCT02236481 Phase 4
12 REstore Working Ability in RheumatoiD Arthritis Unknown status NCT01405326 Phase 4
13 Rheumatoid Arthritis Patients in Training Unknown status NCT00434200 Phase 4
14 Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) Unknown status NCT01067430 Phase 4
15 Hanyang University Medical Center Arthritis Network Unknown status NCT00418405 Phase 4
16 Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. Unknown status NCT01835613 Phase 4
17 Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis Unknown status NCT00216177 Phase 4
18 Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine Unknown status NCT01980836 Phase 4
19 Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Unknown status NCT02132234 Phase 4
20 Bucillamine Study of Holding Remission After Infliximab Dose-off Unknown status NCT00716248 Phase 4
21 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Unknown status NCT01282528 Phase 4
22 Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar® Unknown status NCT00828997 Phase 4
23 Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate Unknown status NCT01270035 Phase 4
24 Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) Unknown status NCT01303874 Phase 4
25 Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis Unknown status NCT00291915 Phase 4
26 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
27 The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis Unknown status NCT01088165 Phase 4
28 Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis Unknown status NCT02355236 Phase 4
29 Close Kinect Chain Exercise With Kinesio Taping in the Management of Patellofemoral Pain Syndrome Unknown status NCT02241148 Phase 4
30 The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis Unknown status NCT00808496 Phase 4
31 Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant Unknown status NCT02084446 Phase 4
32 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome Unknown status NCT02370550 Phase 4
33 Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue Unknown status NCT00543166 Phase 4
34 Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis Unknown status NCT02484508 Phase 4
35 Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy Completed NCT00244556 Phase 4
36 Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA) Completed NCT01382160 Phase 4
37 Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis Completed NCT00565409 Phase 4
38 Relaxation Response Training for the Treatment of Rheumatoid Arthritis Completed NCT00056667 Phase 4
39 An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis Completed NCT00896168 Phase 4
40 Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis Completed NCT01207453 Phase 4
41 Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients Completed NCT00650455 Phase 4
42 The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol Completed NCT00246064 Phase 4
43 Treatment of Rheumatoid Arthritis With Roxithromycin Completed NCT00439062 Phase 4
44 Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects Completed NCT00252668 Phase 4
45 ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain. Completed NCT00246168 Phase 4
46 Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis Completed NCT01225991 Phase 4
47 A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA) Completed NCT01185288 Phase 4
48 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis Completed NCT00420927 Phase 4
49 A Study of Iguratimod in Patients With Active Rheumatoid Arthritis Completed NCT01554917 Phase 4
50 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Completed NCT00234897 Phase 4

Search NIH Clinical Center for Rheumatoid Arthritis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Rheumatoid Arthritis cell therapies at LifeMap Discovery.

Cochrane evidence based reviews: arthritis, rheumatoid

Genetic Tests for Rheumatoid Arthritis

Genetic tests related to Rheumatoid Arthritis:

id Genetic test Affiliating Genes
1 Rheumatoid Arthritis 29

Anatomical Context for Rheumatoid Arthritis

MalaCards organs/tissues related to Rheumatoid Arthritis:

39
T Cells, Bone, Lung, Monocytes, Endothelial, B Cells, Neutrophil

The Foundational Model of Anatomy Ontology organs/tissues related to Rheumatoid Arthritis:

18
Joint
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Rheumatoid Arthritis:
id Tissue Anatomical CompartmentCell Relevance
1 Cartilage Temporomandibular Joint Affected by disease

Publications for Rheumatoid Arthritis

Articles related to Rheumatoid Arthritis:

(show top 50) (show all 8279)
id Title Authors Year
1
The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study. ( 28086960 )
2017
2
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration. ( 28089978 )
2017
3
The functional variants of endothelial nitric oxide synthase gene associated with rheumatoid arthritis in Turkish adults. ( 27695991 )
2017
4
CD147 modulates the differentiation of T-helper 17 cells in patients with rheumatoid arthritis. ( 27859685 )
2017
5
Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis. ( 28088452 )
2017
6
Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients. ( 28496328 )
2017
7
Lichen amyloidosis associated with rheumatoid arthritis: unique presentation in a Bulgarian patient. ( 28076615 )
2017
8
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. ( 28087506 )
2017
9
CCR5I932 and the genetic susceptibility to rheumatoid arthritis in admixed populations: a multicentre study. ( 28082621 )
2017
10
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis. ( 28529116 )
2017
11
Factors associated with hand joint destruction in Chinese patients with rheumatoid arthritis. ( 28532395 )
2017
12
Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report. ( 28487504 )
2017
13
Disease Characteristics and Rheumatoid Arthritis Development in Patients with Early Undifferentiated Arthritis: A 2-year Followup Study. ( 28089976 )
2017
14
Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project. ( 28042124 )
2017
15
Focal segmental glomerulosclerosis lagged behind the onset of rheumatoid arthritis by 7 years: A case report and literature review. ( 28072731 )
2017
16
Ex vivo all-trans retinoic acid modulates NO production and regulates IL-6 effect during rheumatoid arthritis: a study in Algerian patients. ( 28211306 )
2017
17
TNFR1 and TNFR2 differentially mediate TNF-I+-induced inflammatory responses in rheumatoid arthritis fibroblast-like synoviocytes. ( 28150360 )
2017
18
Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study. ( 28089982 )
2017
19
Association between circulating transforming growth factor-I^1 level and polymorphisms in systemic lupus erythematosus and rheumatoid arthritis: A meta-analysis. ( 28234629 )
2017
20
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine. ( 28081972 )
2017
21
The coexistence of SAPHO syndrome and rheumatoid arthritis: A case report. ( 28072711 )
2017
22
Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies. ( 28154345 )
2017
23
Genetic association of aromatic hydrocarbon receptor and its repressor gene polymorphisms with risk of rheumatoid arthritis in Han Chinese populations. ( 28403070 )
2017
24
Interleukin 12B gene polymorphisms and susceptibility to rheumatoid arthritis: a data synthesis. ( 27312970 )
2017
25
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. ( 28081709 )
2017
26
Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis. ( 28083614 )
2017
27
Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease? ( 28086844 )
2017
28
Tear Fluid Protein Changes in Dry Eye Syndrome Associated with Rheumatoid Arthritis: A Proteomic Approach. ( 27789276 )
2017
29
Need for improvements in reported cost effectiveness ofA adalimumab in rheumatoid arthritis. ( 28084542 )
2017
30
Abnormal Glucose Metabolism in Rheumatoid Arthritis. ( 28529957 )
2017
31
A Retrospective Analysis of Subaxial Subluxation After Atlanto-axial Arthrodesis in Patients With Rheumatoid Arthritis Based on Annual Radiographs Obtained for 5 Years. ( 28525484 )
2017
32
Inflammation Is an Important Covariate for the Crosstalk of Sleep and the HPA Axis in Rheumatoid Arthritis. ( 28535535 )
2017
33
Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis. ( 28215593 )
2017
34
Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study. ( 28534075 )
2017
35
Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis. ( 27423206 )
2017
36
Effect of 1,25-(OH)2D3 on Proliferation of Fibroblast-Like Synoviocytes and Expressions of Pro-Inflammatory Cytokines through Regulating MicroRNA-22 in a Rat Model of Rheumatoid Arthritis. ( 28528333 )
2017
37
Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis. ( 28087832 )
2017
38
Induction and Differentiation of IL-10-Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients. ( 28087671 )
2017
39
Power Doppler signal calibration in the finger joint between two models of ultrasound machine: a pilot study using a phantom and joints in patients with rheumatoid arthritis. ( 28084811 )
2017
40
Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability. ( 28532452 )
2017
41
Translation, cultural adaptation and validation of the English "Short form SF 12v2" into Bengali in rheumatoid arthritis patients. ( 28532468 )
2017
42
Lack of Association between STAT4 Single Nucleotide Polymorphisms and Iranian Juvenile Rheumatoid Arthritis Patients. ( 28524764 )
2017
43
Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives. ( 28526580 )
2017
44
Micro RNA-146a But Not IRAK1 is Associated with Rheumatoid Arthritis in the Tunisian Population. ( 28207326 )
2017
45
A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris. ( 27814654 )
2017
46
Unaffected reaction level in tuberculin skin test by long-term therapy with tumor necrosis factor inhibitors for rheumatoid arthritis. ( 28524434 )
2017
47
Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece. ( 28523420 )
2017
48
Association of NKG2D gene variants with susceptibility and severity of rheumatoid arthritis. ( 27783394 )
2017
49
Cervical spine involvement risk factors in rheumatoid arthritis: a meta-analysis. ( 28524646 )
2017
50
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. ( 28057661 )
2017